Cargando…
Efficacy and safety of a food supplement with standardized menthol, limonene, and gingerol content in patients with irritable bowel syndrome: A double-blind, randomized, placebo-controlled trial
BACKGROUND: Irritable bowel syndrome (IBS) affects 9,2% of the global population and places a considerable burden on healthcare systems. Most medications for treating IBS, including spasmolytics, laxatives, and antidiarrheals, have low efficacy. Effective and safe therapeutic treatments have yet to...
Autores principales: | Ivashkin, Vladimir T., Kudryavtseva, Anna V., Krasnov, George S., Poluektov, Yuri M., Morozova, Margarita A., Shifrin, Oleg S., Beniashvili, Allan G., Mamieva, Zarina A., Kovaleva, Alexandra L., Ulyanin, Anatoly I., Trush, Elizaveta A., Erlykin, Alexander G., Poluektova, Elena A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9200470/ https://www.ncbi.nlm.nih.gov/pubmed/35704960 http://dx.doi.org/10.1371/journal.pone.0263880 |
Ejemplares similares
-
Antibiotics, gut microbiota, and irritable bowel syndrome: What are the relations?
por: Mamieva, Zarina, et al.
Publicado: (2022) -
Disruption of the pro-inflammatory, anti-inflammatory cytokines and tight junction proteins expression, associated with changes of the composition of the gut microbiota in patients with irritable bowel syndrome
por: Ivashkin, V., et al.
Publicado: (2021) -
Efficacy of a Probiotic Consisting of Lacticaseibacillus rhamnosus PDV 1705, Bifidobacterium bifidum PDV 0903, Bifidobacterium longum subsp. infantis PDV 1911, and Bifidobacterium longum subsp. longum PDV 2301 in the Treatment of Hospitalized Patients with COVID-19: a Randomized Controlled Trial
por: Ivashkin, Vladimir, et al.
Publicado: (2021) -
Effect of Rebamipide on the Intestinal Barrier, Gut Microbiota Structure and Function, and Symptom Severity Associated with Irritable Bowel Syndrome and Functional Dyspepsia Overlap: A Randomized Controlled Trial
por: Kovaleva, Aleksandra, et al.
Publicado: (2023) -
Clostridioides difficile co-infection in patients with COVID-19
por: Maslennikov, Roman, et al.
Publicado: (2022)